Jorge L. Ortiz Criado

Array ( [id] => 3784307 [patent_doc_number] => 05840507 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Methods for cancer prognosis and diagnosis' [patent_app_type] => 1 [patent_app_number] => 8/843008 [patent_app_country] => US [patent_app_date] => 1997-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5622 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 335 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840507.pdf [firstpage_image] =>[orig_patent_app_number] => 843008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4200778 [patent_doc_number] => 06013765 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Isolated tumor rejection antigens derived from DAGE tumor rejection antigen precusor' [patent_app_type] => 1 [patent_app_number] => 8/809999 [patent_app_country] => US [patent_app_date] => 1997-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 9379 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013765.pdf [firstpage_image] =>[orig_patent_app_number] => 809999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3930803 [patent_doc_number] => 05980912 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Chitosan induced immunopotentiation' [patent_app_type] => 1 [patent_app_number] => 8/823143 [patent_app_country] => US [patent_app_date] => 1997-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5238 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/980/05980912.pdf [firstpage_image] =>[orig_patent_app_number] => 823143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3989044 [patent_doc_number] => 05919456 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'IL-13 receptor specific chimeric proteins' [patent_app_type] => 1 [patent_app_number] => 8/821840 [patent_app_country] => US [patent_app_date] => 1997-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14364 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919456.pdf [firstpage_image] =>[orig_patent_app_number] => 821840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3977645 [patent_doc_number] => 05917021 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Stabilized monomeric protein compositions' [patent_app_type] => 1 [patent_app_number] => 8/819033 [patent_app_country] => US [patent_app_date] => 1997-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5114 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/917/05917021.pdf [firstpage_image] =>[orig_patent_app_number] => 819033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3810633 [patent_doc_number] => 05854404 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Antitumor substance extracted from grifola' [patent_app_type] => 1 [patent_app_number] => 8/812795 [patent_app_country] => US [patent_app_date] => 1997-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1718 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854404.pdf [firstpage_image] =>[orig_patent_app_number] => 812795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4102657 [patent_doc_number] => 06066719 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Antibody fragments' [patent_app_type] => 1 [patent_app_number] => 8/811757 [patent_app_country] => US [patent_app_date] => 1997-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 13717 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066719.pdf [firstpage_image] =>[orig_patent_app_number] => 811757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3941694 [patent_doc_number] => 05976811 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Antibodies for the selective immunological determination of bile acids in biological matrices' [patent_app_type] => 1 [patent_app_number] => 8/807457 [patent_app_country] => US [patent_app_date] => 1997-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3735 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/976/05976811.pdf [firstpage_image] =>[orig_patent_app_number] => 807457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4225332 [patent_doc_number] => 06011138 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Gamma-1 anti-human CD23 monoclonal antibodies' [patent_app_type] => 1 [patent_app_number] => 8/803085 [patent_app_country] => US [patent_app_date] => 1997-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 23010 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/011/06011138.pdf [firstpage_image] =>[orig_patent_app_number] => 803085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4034331 [patent_doc_number] => 05994504 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Vitamin D response element binding protein' [patent_app_type] => 1 [patent_app_number] => 8/799429 [patent_app_country] => US [patent_app_date] => 1997-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8239 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994504.pdf [firstpage_image] =>[orig_patent_app_number] => 799429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4054276 [patent_doc_number] => 05932706 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'Antibodies specific for a haemostatic protein their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein' [patent_app_type] => 1 [patent_app_number] => 8/797842 [patent_app_country] => US [patent_app_date] => 1997-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8376 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932706.pdf [firstpage_image] =>[orig_patent_app_number] => 797842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3970716 [patent_doc_number] => 05916570 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection' [patent_app_type] => 1 [patent_app_number] => 8/795294 [patent_app_country] => US [patent_app_date] => 1997-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3062 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/916/05916570.pdf [firstpage_image] =>[orig_patent_app_number] => 795294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3888533 [patent_doc_number] => 05777084 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Antibody BV10A4H2 specific for human FLT3/FLK2 receptor and mybridoma' [patent_app_type] => 1 [patent_app_number] => 8/792626 [patent_app_country] => US [patent_app_date] => 1997-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 3325 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/777/05777084.pdf [firstpage_image] =>[orig_patent_app_number] => 792626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4105653 [patent_doc_number] => 06100386 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Human gene/protein involved in chronic myelogenous leukemia' [patent_app_type] => 1 [patent_app_number] => 8/787091 [patent_app_country] => US [patent_app_date] => 1997-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15638 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100386.pdf [firstpage_image] =>[orig_patent_app_number] => 787091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3804960 [patent_doc_number] => 05854027 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Process for improving the stability of antibodies' [patent_app_type] => 1 [patent_app_number] => 8/765179 [patent_app_country] => US [patent_app_date] => 1997-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 14641 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 568 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854027.pdf [firstpage_image] =>[orig_patent_app_number] => 765179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4125716 [patent_doc_number] => 06033674 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Method of treating cancer with a tumor cell line having modified cytokine expression' [patent_app_type] => 1 [patent_app_number] => 8/773367 [patent_app_country] => US [patent_app_date] => 1996-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9113 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/033/06033674.pdf [firstpage_image] =>[orig_patent_app_number] => 773367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3741567 [patent_doc_number] => 05801004 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Method for detecting prostatic cancer' [patent_app_type] => 1 [patent_app_number] => 8/771963 [patent_app_country] => US [patent_app_date] => 1996-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3581 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/801/05801004.pdf [firstpage_image] =>[orig_patent_app_number] => 771963 [rel_patent_id] =>[rel_patent_doc_number] =>)